In China, Mounjaros addition to the National Reimbursed Drug List (NRDL, meaning government-approved coverage) drove volume growth that far outpaced the accompanying price concession
Signs of thyroid tumor (neck lump, hoarseness) reported in rodent studies
Retatrutide, the triple receptor agonist targeting GLP-1 , GIP, and glucagon receptors simultaneously, requires precise dosing that changes every four weeks as you titrate upward
Key Takeaways Semaglutide, Tirzepatide, and Retatrutide are GLP-1 (glucagon-like peptide-1) medications, each offering increasing efficacy through multi-receptor targeting
PeptideStack does not provide medical advice, diagnosis, treatment recommendations, dosing guidance, or instructions for human use
Common side effects of GLP-1 drugs as a class include nausea, vomiting, diarrhea, constipation, stomach pain, and decreased appetite